Regional Control of Head and Neck Melanoma With Selective Neck Dissection

被引:12
|
作者
Geltzeiler, Mathew [1 ]
Monroe, Marcus [1 ]
Givi, Babak [1 ]
Vetto, John [2 ]
Andersen, Peter [1 ]
Gross, Neil [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Surg, Div Surg Oncol, Portland, OR 97239 USA
关键词
LYMPH-NODE DISSECTION; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; CUTANEOUS MELANOMA; LYMPHADENECTOMY; MANAGEMENT; EFFICACY; BIOPSY;
D O I
10.1001/jamaoto.2014.2056
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
IMPORTANCE Historically, patients with cervical metastases from melanoma of the head and neck were treated with a radical neck dissection. This study evaluates the efficacy of limiting the extent of lymphadenectomy in this high-risk population. OBJECTIVES To determine whether limiting the extent of lymphadenectomy for patients with biopsy-proven melanoma has a negative effect on regional control. Our hypothesis was that performing a more limited lymphadenectomy does not have a negative impact on regional control. DESIGN, SETTING, AND PARTICIPANTS A retrospective, single-cohort study was performed using a prospectively collected database of patients with head and neck melanoma with histopathologically positive lymph nodes after modified radical (MRND) or selective neck dissection (SNDs) performed at a high-volume, academic, tertiary care center. INTERVENTIONS Lymphadenectomy was performed as clinically indicated. MAIN OUTCOMES AND MEASURES Primary end points were regional recurrence and regional recurrence free survival. Univariable and multivariable analyses were conducted using multiple patient characteristics. RESULTS Forty-one patients underwent SND or MRND from 2001 through 2010. The median number of positive nodes was 1 (range, 1-16). Twenty-six patients (63%) received adjuvant radiation and 23 patients (56%) received adjuvant immunotherapy or chemotherapy. The median follow-up time was 17 months (range, 1-116 months). Regional control was achieved in 29 patients (71%). Median regional recurrence-free survival was 21 months (range, 1-116 months). Age (hazard ratio [HR], 1.13; 95% CI, 1.01-1.26), total number of nodes examined (HR, 1.05; 95% CI, 1.01-1.10), and number of sentinel lymph nodes examined (HR, 1.45; 95% CI, 1.01-2.09) were all significantly associated with increased recurrence-free survival. Tumor depth, extracapsular spread, number of nodes positive, prior SLNB, extent of lymphadenectomy, and adjuvant therapy were not significant. CONCLUSIONS AND RELEVANCE Limiting the extent of lymphadenectomy with frequent use of adjuvant radiation therapy is effective in achieving regional control of head and neck melanoma with cervical metastases.
引用
收藏
页码:1014 / 1018
页数:5
相关论文
共 50 条
  • [31] RADICAL NECK DISSECTION IN CARCINOMA OF HEAD AND NECK
    KERTH, JD
    SISSON, GA
    BECKER, GD
    SURGICAL CLINICS OF NORTH AMERICA, 1973, 53 (01) : 179 - 190
  • [32] Effectiveness of selective neck dissection in head and neck cancer: The experience of two Italian centers
    Barzan, Luigi
    Talamini, Renato
    Franchin, Giovanni
    Pin, Marco
    Silvestrini, Marina
    Grando, Giuseppe
    Galla, Stefania
    Savignano, Maria Gabriella
    Armas, Gianluca
    Margiotta, Francesco
    Vanoni, Valentina
    Magri, Elena
    Grandi, Cesare
    LARYNGOSCOPE, 2015, 125 (08): : 1849 - 1855
  • [33] Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma
    Sandra Schmitz
    Jean-Pascal Machiels
    Birgit Weynand
    Vincent Gregoire
    Marc Hamoir
    European Archives of Oto-Rhino-Laryngology, 2009, 266 : 437 - 443
  • [34] Selective Neck Dissection in Node-Positive Squamous Cell Carcinoma of the Head and Neck
    Givi, Babak
    Linkov, Gary
    Ganly, Ian
    Patel, Snehal G.
    Wong, Richard J.
    Singh, Bhuvanesh
    Boyle, Jay O.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 147 (04) : 707 - 715
  • [35] Selective neck dissection and sentinel node biopsy in head and neck squamous cell carcinomas
    Mamelle, G
    LYMPHATIC METASTASIS AND SENTINEL LYMPHONODECTOMY, 2000, 157 : 193 - 200
  • [36] Role of Planned Postchemoradiotherapy Selective Neck Dissection in the Multimodality Management of Head and Neck Cancer
    Nouraei, S. A. Reza
    Upile, Tahwinder
    Al-Yaghchi, Chadwan
    Lei, Mary
    Sandhu, Guri S.
    Stewart, Simon
    Clarke, Peter M.
    Sandison, Ann
    LARYNGOSCOPE, 2008, 118 (05): : 797 - 803
  • [37] Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma
    Schmitz, Sandra
    Machiels, Jean-Pascal
    Weynand, Birgit
    Gregoire, Vincent
    Hamoir, Marc
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2009, 266 (03) : 437 - 443
  • [38] SELECTIVE NECK DISSECTION
    HAINS, D
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1994, 64 (11): : 797 - 797
  • [39] Head and Neck Melanoma
    Cheriyan, Jerry
    Wernberg, Jessica
    Urquhart, Andrew
    SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (05) : 1091 - +
  • [40] MELANOMA OF HEAD AND NECK
    CONLEY, J
    HAMAKER, RC
    LARYNGOSCOPE, 1977, 87 (05): : 760 - 764